Mikobakteriyel Enfeksiyonların Tanısında Biyokimyasal, İmmünometabolik ve Moleküler Belirteçler
References
World Health Organization. Global Tuberculosis Report 2024. Geneva: World Health Organization; 2024.
T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Tüberküloz Tanı ve Tedavi Rehberi. Ankara: Sağlık Bakanlığı Yayınları; 2019.
Sabella-Jiménez V, Restrepo-Espinosa V, Silvera AA, et al. Performance of Xpert MTB/RIF and acid-fast bacilli smear microscopy for the diagnosis of pulmonary tuberculosis using bronchoalveolar lavage samples in negative or sputum-scarce adults in Colombia: a retrospective diagnostic accuracy study. BMC Infect Dis. 2025;25(1):491. doi:10.1186/s12879-025-10856-z.
Umair M, Siddiqui SA, Farooq MA. Diagnostic accuracy of sputum microscopy in comparison with GeneXpert in pulmonary tuberculosis. Cureus. 2020;12(11):e11576. doi:10.7759/cureus.11576.
Passos BBS, Araújo-Pereira M, Vinhaes CL, et al. The role of ESAT-6 in tuberculosis immunopathology. Front Immunol. 2024;15:1383098. doi:10.3389/fimmu.2024.1383098.
Zhulai G, Oleinik E, Shibaev M, et al. Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer. Biomolecules. 2022;12(3):418. doi:10.3390/biom12030418.
Flinn AM, Gennery AR. Adenosine deaminase deficiency: a review. Orphanet Journal of Rare Diseases. 2018;13:65. doi:10.1186/s13023-018-0807-5.
Li H, Zhang Y, Wu Z, et al. The value of adenosine deaminase 2 in the diagnosis of tuberculous pleural effusion: a systematic review and meta-analysis. BMC Infectious Diseases. 2022;22(1):189. doi:10.1186/s12879-022-07231-7.
Burgess LJ, Maritz FJ, Le Roux I, et al. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. International Journal of Tuberculosis and Lung Disease. 2005;9(2):212–217.
Liang QL, Shi HZ, Wang K, Qin SM, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respiratory Medicine. 2008;102(5):744-754. doi:10.1016/j.rmed.2007.12.007.
Porcel JM, Light RW. Diagnostic approach to pleural effusion in adults. American Family Physician. 2006;73(7):1211–1220.
Janković J, Ilić B, Đurđević N, et al. ADA as main biochemical marker in patients with tuberculous effusion. Journal of Medical Biochemistry. 2023;42(4):722-726. doi:10.5937/jomb0-44018.
Pormohammad A, Riahi SM, Nasiri MJ, et al. Diagnostic accuracy of adenosine deaminase for tuberculous meningitis: a systematic review and meta-analysis. Journal of Infection and Public Health. 2017;10(5):545–554.
Ye Q, Yan W. Adenosine deaminase from the cerebrospinal fluid for the diagnosis of tuberculous meningitis: A meta-analysis. Tropical Medicine & International Health. 2023;28(3):175–185. doi:10.1111/tmi.13849.
Song J, Kim S-H, Jung Y-R, et al. 10-Year Retrospective Review of the Etiologies for Meningitis With Elevated Adenosine Deaminase in Cerebrospinal Fluid: Etiologies Other Than TB. Frontiers in Cellular and Infection Microbiology. 2022;12:858724. doi:10.3389/fcimb.2022.858724.
Paris L, Magni R, Zaidi F, et al. Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity. Science Translational Medicine. 2017;9(420):eaal2807. doi:10.1126/scitranslmed.aal2807.
Broger T, Nicol MP, Sigal GB, et al. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in HIV-positive inpatients. The Lancet Global Health. 2019;7(6):e782–e791.
Gupta-Wright A, Peters JA, Flach C, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients. The Lancet. 2018;392(10148):716–726.
Eckersall PD, Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. The Veterinary Journal. 2010;185(1):23–27.
Yoon C, Chaisson LH, Patel SM, et al. Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis. Clinical Infectious Diseases. 2017;65(3):441–449. doi:10.1093/cid/cix411.
Sabiiti W, Azam K, Farmer ECW, et al. Tuberculosis treatment response monitoring using C-reactive protein. Scientific Reports. 2020;10:14457. doi:10.1038/s41598-020-71242-3.
Dheda K, Gumbo T, Maartens G, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. The Lancet Respiratory Medicine. 2017;5(4):291-360. doi:10.1016/S2213-2600(17)30079-6.
Brigden ML. Clinical utility of the erythrocyte sedimentation rate. American Family Physician. 1999;60(5):1443-1450.
Ferrer J. Pleural tuberculosis. European Respiratory Journal. 1997;10(4):942-947. doi:10.1183/09031936.97.10040942.
Hiyama J, Marukawa M, Shiota Y, et al. Factors influencing response to treatment of pulmonary tuberculosis. Acta Medica Okayama. 2000;54(4):139-145. doi:10.18926/AMO/32276.
Kawka M, Brzostek A, Dzitko K, et al. Mycobacterium tuberculosis binds human serum amyloid A, and the interaction modulates the colonization of human macrophages and the transcriptional response of the pathogen. Cells. 2021;10(5):1264. doi:10.3390/cells10051264.
Kim J, Kim SE, Park BS, et al. Procalcitonin as a diagnostic and prognostic factor for tuberculosis meningitis. Journal of Clinical Neurology. 2016;12(3):332-339. doi:10.3988/jcn.2016.12.3.332.
Wei TT, Hu ZD, Qin BD, et al. Diagnostic accuracy of procalcitonin in bacterial meningitis versus nonbacterial meningitis: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(11):e3079. doi:10.1097/MD.0000000000003079.
Johnson DA, Smith KD. The efficacy of certain anti-tuberculosis drugs is affected by binding to α-1-acid glycoprotein. Biomedical Chromatography. 2006;20(6-7):551-560. doi:10.1002/bmc.641.
Dasaradhan T, Natarajan M, Kumar S, et al. Tuberculosis-associated anemia: a narrative review of mechanisms and clinical implications. Journal of Infection and Public Health. 2022;15(9):1023-1031. doi:10.1016/j.jiph.2022.07.012.
Fauchald T, Blomberg B, Reikvam H. Tuberculosis-associated hemophagocytic lymphohistiocytosis: a systematic review of cases and clinical features in the English literature. Journal of Clinical Medicine. 2023;12(16):5366. doi:10.3390/jcm12165366.
Gopal R, Monin L, Torres D, et al. S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. American Journal of Respiratory and Critical Care Medicine. 2013;188(9):1137-1146. doi:10.1164/rccm.201304-0803OC.
Koochakzai O, Shen Y, Pormohammad A, et al. Elevated neopterin in tuberculosis and co-infection with HIV and the effect of treatment: A systematic review, meta-analysis, and meta-regression. International Immunopharmacology.2022;111:109147.doi:10.1016/j.intimp.2022.109147.
Adekambi T, Ibegbu C, Kalokhe AS, et al. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis. PLoS One. 2012;7(4):e36046. doi:10.1371/journal.pone.0036046.
Naranbhai V, Hill PC, Abdool Karim SS, et al. Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis. Nature Communications. 2014;5:4732. doi:10.1038/ncomms5732.
Adane T, Melku M, Ayalew G, et al. Accuracy of monocyte to lymphocyte ratio for tuberculosis diagnosis and its role in monitoring anti-tuberculosis treatment: systematic review and meta-analysis. Medicine(Baltimore).2022;101(44):e31539.doi:10.1097/MD.0000000000031539.
Chen G, Wu C, Luo Z, et al. Platelet-lymphocyte ratios: a potential marker for pulmonary tuberculosis diagnosis in COPD patients. International Journal of Chronic Obstructive Pulmonary Disease. 2016;11:2737-2740. doi:10.2147/COPD.S111254. PMID:27843310; PMCID:PMC5098523.
Gunluoglu G, Yazar EE, Veske NS, et al. Mean platelet volume as an inflammation marker in active pulmonary tuberculosis. Multidisciplinary Respiratory Medicine. 2014;9:11. doi:10.1186/2049-6958-9-11.
Xu F, Zhang H, Si X, et al. Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis. BMC Immunology. 2021;22(1):41. doi:10.1186/s12865-021-00430-y. PMID:34176483; PMCID:PMC8237462.
Portevin D, Moukambi F, Clowes P, et al. Assessment of the novel T-cell activation marker–tuberculosis assay for diagnosis of active tuberculosis in children: a prospective proof-of-concept study. Lancet Infect Dis. 2014;14(10):931-938. doi:10.1016/S1473-3099(14)70884-9.
Gatti A, Ceriani C, De Paschale M, et al. Quantification of neutrophil and monocyte CD64 expression: a predictive biomarker for active tuberculosis. International Journal of Tuberculosis and Lung Disease. 2020;24(2):196-201. doi:10.5588/ijtld.19.0147. PMID:32127104.
Day CL, Abrahams D, Bunjun R, et al. PD-1 expression on Mycobacterium tuberculosis-specific CD4 T cells is associated with bacterial load in human tuberculosis. Front Immunol. 2018;9:1995. doi:10.3389/fimmu.2018.01995.PMID:30233588;PMCID:PMC6127207.
Liang QL, Shi HZ, Qin SM, et al. Diagnostic value of interferon-gamma in tuberculous pleurisy: a meta-analysis. Chest. 2007;131(4):1133-1141.doi:10.1378/chest.06-2273. PMID:17426220.
Aggarwal AN, Agarwal R, Dhooria S, et al. Unstimulated pleural fluid interferon gamma for diagnosis of tuberculous pleural effusion: a systematic review and meta-analysis. J Clin Microbiol. 2021;59(5):e02112-20.doi:10.1128/JCM.02112-20. PMID:33208475; PMCID:PMC8091832.
Liu Q, Yu Y-X, Wang X-J, et al. Diagnostic accuracy of interleukin-27 between tuberculous pleural effusion and malignant pleural effusion: a meta-analysis. Respiration. 2018;95(6):469-477. doi:10.1159/000486963. PMID:29539604.
Tong X, Lu H, Yu M, et al. Diagnostic value of interferon-γ-induced protein of 10kDa for tuberculous pleurisy: a meta-analysis. Clin Chim Acta. 2017;471:143-149. doi:10.1016/j.cca.2017.05.034. PMID:28577960.
Mardining Raras TY, Astuti T, Noor Chozin I. Soluble urokinase plasminogen activator receptor levels in tuberculosis patients at high risk for multidrug resistance. Tuberculosis Research and Treatment. 2012;2012:240132. doi:10.1155/2012/240132.
Steingart KR, Dendukuri N, Henry M, et al. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clinical and Vaccine Immunology. 2009;16(2):260-276. doi:10.1128/CVI.00355-08.
Kunnath-Velayudhan S, Salamon H, Wang HY, et al. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(33):14703 14708. doi:10.1073/pnas.1009080107.
Warsinske H, Vashisht R, Khatri P. Host-response-based gene signatures for tuberculosis diagnosis: a systematic comparison of 16 signatures. PLoS Medicine. 2019;16(4):e1002786. doi:10.1371/journal.pmed.1002786.
Ma F, Xu S, Liu X, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nature Immunology. 2011;12(9):861-869. doi:10.1038/ni.2073.
Wang L, Xiong Y, Fu B, et al. MicroRNAs as immune regulators and biomarkers in tuberculosis. Frontiers in Immunology. 2022;13:1027472. doi:10.3389/fimmu.2022.1027472.
El-Masry EA, Samir M, Taha AE. Candidate blood microRNAs as potential biomarkers in patients with active and latent pulmonary tuberculosis infection. Journal of Pure and Applied Microbiology. 2024;18(1):568-583. doi:10.22207/JPAM.18.1.40.
Sweeney TE, Braviak L, Tato CM, et al. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Infect Dis. 2016;16(3):e45-e57. doi:10.1016/S1473-3099(15)00416-2.
Warsinske HC, Rao AM, Moreira FMF, et al. Assessment of validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity, and treatment response. JAMA Network Open. 2018;1(6):e183779. doi:10.1001/jamanetworkopen.2018.3779.
Collins JM, Siddiqa A, Jones DP, et al. Tryptophan catabolism reflects disease activity in human tuberculosis. Journal of Clinical Investigation. 2020;130(5): 2471–2484. doi:10.1172/JCI137131.
Shukla R, Kalita J, Haldar R, et al. Blood-CSF-barrier permeability in tuberculous meningitis and its association with clinical, MRI and inflammatory cytokines. Journal of Neuroimmunology. 2022;372:577954. doi:10.1016/j.jneuroim.2022.577954.
Wang JL, Han C, Yang FL, et al. Normal cerebrospinal fluid protein and associated clinical characteristics in children with tuberculous meningitis. Annals of Medicine. 2021;53:885–889. doi:10.1080/07853890.2021.1937692.
Jacobs L, Delsaut B, Lamartine S, et al. Froin’s syndrome: a comprehensive review of the literature and the addition of two new cases. Neurology International. 2024;16(5):1112-1121. doi:10.3390/neurolint16050083.
Dian S, Ardiansyah E, Chaidir L, et al. Clinical significance of hyponatremia in tuberculous meningitis: a prospective cohort in Indonesia. Open Forum Infectious Diseases. 2024;11(12): ofae673. doi:10.1093/ofid/ofae673.